- Virios Therapeutics press release (NASDAQ:VIRI): Q4 GAAP EPS of -$0.06.
- As of December 31, 2023, Virios Therapeutics' (VIRI) cash totaled $3.3M. The company believes it has sufficient resources to fund operations into the fourth quarter of 2024.
Virios Therapeutics reports Q4 results
Recommended For You
More Trending News
About VIRI Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| VIRI | - | - |
| Virios Therapeutics, Inc. | ||